These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 34327239)

  • 21. Treatment Strategies for Hepatocellular Carcinoma ⁻ a Multidisciplinary Approach.
    Lurje I; Czigany Z; Bednarsch J; Roderburg C; Isfort P; Neumann UP; Lurje G
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model.
    Walker S; Wankell M; Ho V; White R; Deo N; Devine C; Dewdney B; Bhathal P; Govaere O; Roskams T; Qiao L; George J; Hebbard L
    PLoS One; 2019; 14(2):e0212860. PubMed ID: 30794695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein Nanotherapeutics as an Emerging Modality for Cancer Therapy.
    Cheng L; Yang L; Meng F; Zhong Z
    Adv Healthc Mater; 2018 Oct; 7(20):e1800685. PubMed ID: 30240152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray.
    Wu M; Liu H; Liu Z; Liu C; Zhang A; Li N
    J Int Med Res; 2018 Oct; 46(10):4297-4305. PubMed ID: 30111217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White paper on microbial anti-cancer therapy and prevention.
    Forbes NS; Coffin RS; Deng L; Evgin L; Fiering S; Giacalone M; Gravekamp C; Gulley JL; Gunn H; Hoffman RM; Kaur B; Liu K; Lyerly HK; Marciscano AE; Moradian E; Ruppel S; Saltzman DA; Tattersall PJ; Thorne S; Vile RG; Zhang HH; Zhou S; McFadden G
    J Immunother Cancer; 2018 Aug; 6(1):78. PubMed ID: 30081947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using Nanoparticles in Medicine for Liver Cancer Imaging.
    Moghadam FF
    Oman Med J; 2017 Jul; 32(4):269-274. PubMed ID: 28804578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
    Zhang A; Yin C; Wang Z; Zhang Y; Zhao Y; Li A; Sun H; Lin D; Li N
    J Int Med Res; 2016 Dec; 44(6):1414-1423. PubMed ID: 27885040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metal-linked Immunosorbent Assay (MeLISA): the Enzyme-Free Alternative to ELISA for Biomarker Detection in Serum.
    Yu RJ; Ma W; Liu XY; Jin HY; Han HX; Wang HY; Tian H; Long YT
    Theranostics; 2016; 6(10):1732-9. PubMed ID: 27446504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fundamental Properties of One-Dimensional Zinc Oxide Nanomaterials and Implementations in Various Detection Modes of Enhanced Biosensing.
    Hahm JI
    Annu Rev Phys Chem; 2016 May; 67():691-717. PubMed ID: 27215822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying Liver Cancer and Its Relations with Diseases, Drugs, and Genes: A Literature-Based Approach.
    Zhu Y; Song M; Yan E
    PLoS One; 2016; 11(5):e0156091. PubMed ID: 27195695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update of biochemical markers of hepatocellular carcinoma.
    AlSalloom AA
    Int J Health Sci (Qassim); 2016 Jan; 10(1):121-36. PubMed ID: 27004063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective.
    Hafeez Bhatti AB; Dar FS; Waheed A; Shafique K; Sultan F; Shah NH
    Gastroenterol Res Pract; 2016; 2016():5942306. PubMed ID: 26955390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
    Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
    Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A fluorometric microarray with ZnO substrate-enhanced fluorescence and suppressed "coffee-ring" effects for fluorescence immunoassays.
    Li S; Dong M; Li R; Zhang L; Qiao Y; Jiang Y; Qi W; Wang H
    Nanoscale; 2015 Nov; 7(44):18453-8. PubMed ID: 26505964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver cancer biopsy--back to the future?!
    Torbenson M; Schirmacher P
    Hepatology; 2015 Feb; 61(2):431-3. PubMed ID: 25271144
    [No Abstract]   [Full Text] [Related]  

  • 36. Sensitive competitive immunoassay of multiple mycotoxins with non-fouling antigen microarray.
    Hu W; Li X; He G; Zhang Z; Zheng X; Li P; Li CM
    Biosens Bioelectron; 2013 Dec; 50():338-44. PubMed ID: 23880109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.
    Haggar FA; Boushey RP
    Clin Colon Rectal Surg; 2009 Nov; 22(4):191-7. PubMed ID: 21037809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomly oriented ZnO nanorods as advanced substrate for high-performance protein microarrays.
    Hu W; Liu Y; Zhu Z; Yang H; Li CM
    ACS Appl Mater Interfaces; 2010 Jun; 2(6):1569-72. PubMed ID: 20568703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasensitive detection of cytokines enabled by nanoscale ZnO arrays.
    Adalsteinsson V; Parajuli O; Kepics S; Gupta A; Reeves WB; Hahm JI
    Anal Chem; 2008 Sep; 80(17):6594-601. PubMed ID: 18681455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semisynthetic maytansine analogues for the targeted treatment of cancer.
    Widdison WC; Wilhelm SD; Cavanagh EE; Whiteman KR; Leece BA; Kovtun Y; Goldmacher VS; Xie H; Steeves RM; Lutz RJ; Zhao R; Wang L; Blättler WA; Chari RV
    J Med Chem; 2006 Jul; 49(14):4392-408. PubMed ID: 16821799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.